Open AccessManagement of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation
Author(s) -
Victor Pîrvu,
Angela Peltec,
Adrian Hotineanu
Publication year - 2022
Publication title -
buletinul academiei de ştiinţe a moldovei: ştiinţe medicale
Language(s) - English
Resource type - Journals
ISSN - 1857-0011
DOI - 10.52692/1857-0011.2021.3-71.29
Subject(s) - medicine , liver transplantation , hepatocellular carcinoma , waiting list , liver disease , transplantation , gastroenterology , model for end stage liver disease , cirrhosis , stage (stratigraphy) , intensive care medicine , surgery , biology , paleontology
The results of liver transplantation are excellent, with survival rates of over 90 and 80% at 1 and 5 years, respectively. The success of liver transplantation has led to an increase in the indications for liver transplantation. Generally, priorities are given to cirrhotic patients with a high Model for End-Stage Liver Disease (MELD) score on the principle of the sickest first and to patients with hepatocellular carcinoma (HCC) on the principle of priority points according to the size and number of nodules of HCC. These criteria can lead to a ‘competition’ on the waiting list between the above patients and those who are cirrhotic and have an intermediate MELD score or with life-threatening liver diseases not well described by the MELD score. For this latter group of patients, ‘MELD exception’ points can be arbitrarily given.